Author:
Anker M. S.,Hadzibegovic S.,von Haehling S.
Publisher
Springer Science and Business Media LLC
Reference38 articles.
1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:E359–E386
2. Howlader N, Noone AM, Krapcho M, Miller D, Bishop K, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA SEER Cancer Statistics Review (CSR), 1975–2014. Bethesda, MD: National Cancer Institute, based on November 2016 SEER data submission, posted to the SEER web site, April 2017. https://seer.cancer.gov/csr/1975_2014. Zugegriffen: 4. Juni 2018
3. Luengo-Fernandez R, Leal J, Gray A, Sullivan R (2013) Economic burden of cancer across the European Union a population-based cost analysis. Lancet Oncol 14:1165–1174
4. Lagergren P, Schandl A, Aaronson NK, Adami HO, de Lorenzo F, Denis L, Faithfull S, Liu L, Meunier F, Ulrich C (2019) European Academy of Cancer Sciences. Cancer survivorship: an integral part of Europe’s research agenda. Mol Oncol 13:624–635
5. Na SY, Sung JY, Chang JH, Kim S, Lee HH, Park YH, Chung W, Oh KH, Jung JY (2011) Chronic kidney disease in cancer patients: an independent predictor of cancer-specific mortality. Am J Nephrol 33:121–130